The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...